|
 |
European BioPharmaceutical Review
|
'Robot' is a Czech word meaning worker, from the play RUR: Rossums' Universal Robots by the Bohemian writer Karel Capek. The robot has since become an inspiration for science fiction writers and for engineers. Of course the science fiction vision of a robot is a mechanical man, but the reality we see in industry is simply a robotic arm. This is a versatile programmable manipulator, an integration of mechanics, electronics and software, designed interdependently to produce the mechanical equivalent of the computer - an undedicated machine unable to do anything until we program it.
In the pharmaceutical lab it is even less than that definition; the term 'robot' being applied to programmable liquid handlers. Drug development requires the screening of hundreds or thousands of samples and it is in this field that the robot arm is a vital tool. Such an automated screening system is called a 'high-throughput screening' (HTS) system.
|
Read full article >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
Biomarkers in Clinical Trials
23-24 September 2009, London, UK
With an exceptional line-up of speakers, SMi’s Biomarkers in Clinical Trials conference will demonstrate the way forward in designing phase I, II and III trials and present you with a fresh perspective on biomarker application in drug development. This unique event is designed to help you realise the potential of your products in the most efficient way possible and is an essential addition to the calendar of all those working in the industry. Attend and gain insights into the use of biomarkers as a way of accelerating the approval or withdrawal of a product. You will have the chance to network with industry associates and the opportunity to explore ways in which you can integrate biomarkers into your own drug development processes.
More info >> |
|
 |
News and Press Releases |
 |
West and Vetter introduce new WFI Syringe
West (NYSE: WST), the world’s premier manufacturer of components and systems for injectable drug delivery, and Vetter, a worldwide leading independent specialist in the contract manufacturing of prefilled application systems, have introduced a ready-to-use, Water for Injection (WFI) prefilled syringe for reconstituting lyophilised drug products.
More info >> |
|
  |
